Accueil | Fils de syndication
Afficher l'Article
KRAS Mutations Predictive But Not Prognostic in Colorectal Cancer
Keskiviikko, Heinäkuu 02, 2008 - 05:27 - 5 kuukaudet depuis - Presse spécialisée - Medscape hematology oncology
Another study has confirmed that KRAS mutations predict response to cetuximab in colorectal cancer, but shows that they are not prognostic. Medscape Medical News
